Video

Q&A With Colleen Kelly, MD, From Brown Alpert Medical School: Fecal Microbiota Transplant Moves Into Mainstream Treatment for C-Difficie

Author(s):

What once was viewed to be an unscientific approach to help treat C-difficile, fecal microbiota transplant has become not only an accepted method of treatment, but also the preferred method in many patients.

What once was viewed to be an unscientific approach to help treat C-difficile, fecal microbiota transplant has become not only an accepted method of treatment, but also the preferred method in many patients.

Colleen Kelly discussed the procedure during the American College of Physicians Internal Medicine meeting in Boston. As the procedure has developed it has become easier for doctors outside of gastroenterology to handle the transplants in some cases. Kelly said it is important that the donor for the transplant is properly screened to ensure ultimate success.

Related Videos
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.